Positions

Selected Publications

Academic Article

Year Title Altmetric
2018 Blood Viral Load in Symptomatic Congenital Cytomegalovirus Infection.Journal of Infectious Diseases2018
2018 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  7:270-274. 2018
2018 The Tail Wagging the Dog (or the Challenges Faced When the Financing of Medicine Gets Ahead of the Science of Medicine).Journal of Clinical Microbiology.  56. 2018
2018 Antiviral Approaches for the Treatment of Herpes Simplex Virus Infections in Newborn Infants.Annual Review of Virology.  5:407-425. 2018
2018 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  7:181-187. 2018
2018 Antiviral treatment of childhood influenza: an update.Current Opinion in Pediatrics.  30:438-447. 2018
2018 Clinical Markers and Outcomes of Neonates With Herpes Simplex Virus Deoxyribonucleic Acid Persistence in Cerebrospinal Fluid in Disseminated and Central Nervous System Infection.Journal of the Pediatric Infectious Diseases Society.  7:e30-e33. 2018
2018 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  7:93-99. 2018
2018 Closer to Universal Newborn Screening for Congenital Cytomegalovirus Infection but Far Away from Antiviral Therapy in All Infected Infants.Journal of Pediatrics.  199:7-9. 2018
2018 Neonatal herpes simplex virus infectionNeoReviews.  19:e89-e96. 2018
2018 Neonatal HSV Disease: Balancing the Low Incidence With the Need to Treat Promptly.Pediatrics.  141. 2018
2018 Neonatal herpes simplex virus infections.Seminars in Perinatology.  42:168-175. 2018
2017 Pathogenesis of Non-Zika Congenital Viral Infections.Journal of Infectious Diseases.  216:S912-S918. 2017
2017 Antiviral Drugs in Newborn and Children.Pediatric Clinics of North America.  64:1403-1415. 2017
2017 Delayed Recurrence of Herpes Simplex Virus Infection in the Central Nervous System After Neonatal Infection and Completion of Six Months of Suppressive Therapy.Journal of the Pediatric Infectious Diseases Society.  6:e177-e179. 2017
2017 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  6:311-316. 2017
2017 Intravenous Zanamivir in Hospitalized Patients With Influenza.Pediatrics.  140. 2017
2017 Update: Interim Guidance for the Diagnosis, Evaluation, and Management of Infants with Possible Congenital Zika Virus Infection - United States, October 2017.MMWR : Morbidity & Mortality Weekly Report.  66:1089-1099. 2017
2017 Assessing the Febrile Child for Serious Infection: A Step Closer to Meaningful Rapid Results.Pediatrics.  140. 2017
2017 Elimination of Perinatal Hepatitis B: Providing the First Vaccine Dose Within 24 Hours of Birth.Pediatrics.  140. 2017
2017 Fulminant Haemophilus Influenzae Type a Infection in a 4-year-old with Previously Undiagnosed Asplenic Heterotaxy.Pediatric Infectious Disease Journal.  37:e108-e110. 2017
2017 Preventing human papillomavirus-related cancers: we are all in this together.American Journal of Obstetrics and Gynecology.  216:576.e1-576.e5. 2017
2017 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  6:111-115. 2017
2017 Congenital Cytomegalovirus infection: advances and challenges in diagnosis, prevention and treatment.The Italian Journal of Pediatrics.  43:38. 2017
2017 Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy.Lancet Infectious Diseases.  17:e177-e188. 2017
2017 Screening for Congenital Cytomegalovirus After Newborn Hearing Screening: What Comes Next?Pediatrics.  139. 2017
2017 Why neonatal herpes matters.The Lancet Global Health.  5:e234-e235. 2017
2016 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  5:349-355. 2016
2016 Countering Vaccine Hesitancy.Pediatrics.  138. 2016
2016 Medical versus nonmedical immunization exemptions for child care and school attendancePediatrics.  138. 2016
2016 Parental Presence During Treatment of Ebola or Other Highly Consequential Infection.Pediatrics.  138. 2016
2016 Recommendations for serogroup B meningococcal vaccine for persons 10 years and olderPediatrics.  138. 2016
2016 Vaccine Delays, Refusals, and Patient Dismissals: A Survey of Pediatricians.Pediatrics.  138. 2016
2016 Update from the advisory committee on immunization practicesJournal of the Pediatric Infectious Diseases Society.  5:101-104. 2016
2016 A Randomized, Double-Blind, Placebo-Controlled Trial of Pleconaril for the Treatment of Neonates With Enterovirus Sepsis.Journal of the Pediatric Infectious Diseases Society.  5:53-62. 2016
2016 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  5:3-6. 2016
2016 Advances in the prevention and treatment of congenital cytomegalovirus infection.Current Opinion in Pediatrics.  28:81-85. 2016
2015 Sequelae Following Postnatally Acquired Cytomegalovirus Infection in Very Low-Birth-Weight Neonates: Back to the Future.JAMA Pediatrics.  169:e153841. 2015
2015 Neonatal Herpes Simplex Virus Infection.Infectious Disease Clinics of North America.  29:391-400. 2015
2015 Valganciclovir for Congenital Cytomegalovirus.New England Journal of Medicine.  372:2463. 2015
2015 Acyclovir Dosing and Acute Kidney Injury: Deviations and Direction.Journal of Pediatrics.  166:1341-1344. 2015
2015 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  4:94-95. 2015
2015 Quantitative herpes simplex virus concentrations in neonatal infection.Journal of Pediatrics.  166:793-795. 2015
2015 Valganciclovir for symptomatic congenital cytomegalovirus disease.New England Journal of Medicine.  372:933-943. 2015
2015 Neonatal herpes simplex virus infection: epidemiology and treatment.Clinics in Perinatology.  42:47-viii. 2015
2015 Valganciclovir for Symptomatic Congenital Cytomegalovirus DiseaseObstetrical and Gynecological Survey.  70:489-490. 2015
2014 Authors' responses in response to the letter from Ambrose.Pediatrics.  134:e1782-e1783. 2014
2014 Preventing herpes simplex virus in the newborn.Clinics in Perinatology.  41:945-955. 2014
2014 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  3:282-285. 2014
2014 Mother-to-Child Transmission of Herpes Simplex Virus.Journal of the Pediatric Infectious Diseases Society.  3 Suppl 1:S19-S23. 2014
2014 The posology of oseltamivir in infants with influenza infection using a population pharmacokinetic approach.Clinical Pharmacology and Therapeutics.  96:380-389. 2014
2014 Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.Pediatrics.  134:e620-e638. 2014
2014 Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection.Pediatrics.  134:415-420. 2014
2014 Updated recommendations on the use of meningococcal vaccines.Pediatrics.  134:400-403. 2014
2014 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  3:94-97. 2014
2014 Management of neonatal herpes simplex virus infection and exposure.Archives of Disease in Childhood. Fetal and Neonatal Edition.  99:F240-F244. 2014
2014 Pediatric anthrax clinical management.Pediatrics.  133:e1411-e1436. 2014
2014 Authors' response re: Clarifying costs and benefits of respiratory syncytial virus immunoprophylaxis.Pediatrics.  133:e1101-e1103. 2014
2014 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  3:1-3. 2014
2014 Recommended childhood and adolescent immunization schedule--United States, 2014.Pediatrics.  133:357-363. 2014
2014 The scarlet H.Journal of Infectious Diseases.  209:315-317. 2014
2013 Executive summary: Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: Recommendations from the national institutes of health, the centers for disease control and prevention, the HIV medicine association of the infectious diseases society of America, the pediatric infectious diseases society, and the American academy of pediatricsJournal of the Pediatric Infectious Diseases Society.  2:293-308. 2013
2013 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  2:309-311. 2013
2013 RSV immunoprophylaxis: does the benefit justify the cost?Pediatrics.  132:915-918. 2013
2013 Recommendations for prevention and control of influenza in children, 2013-2014.Pediatrics.  132:e1089-e1104. 2013
2013 Acyclovir Dosing in the Neonatal Period and Beyond.Journal of the Pediatric Infectious Diseases Society.  2:179-182. 2013
2013 Update From the Advisory Committee on Immunization Practices.Journal of the Pediatric Infectious Diseases Society.  2:97-99. 2013
2013 A conversation with David W. Kimberlin, MD, FAAP.Pediatric Annals.  42:172. 2013
2013 Neonatal herpes simplex virus infections.Pediatric Clinics of North America.  60:351-365. 2013
2013 Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza.Journal of Infectious Diseases.  207:709-720. 2013
2013 Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.Pediatrics.  131:383-386. 2013
2013 Guidance on management of asymptomatic neonates born to women with active genital herpes lesions.Pediatrics.  131:e635-e646. 2013
2013 Maternal and neonatal herpes simplex virus infections.American Journal of Perinatology.  30:113-119. 2013
2012 Recommendations for prevention and control of influenza in children, 2012-2013.Pediatrics.  130:780-792. 2012
2012 Neonatal herpes disease following maternal antenatal antiviral suppressive therapy: a multicenter case series.Journal of Pediatrics.  161:134-8.e1-3. 2012
2012 Epidemiology and diagnosis of health care-associated infections in the NICU.Pediatrics.  129:e1104-e1109. 2012
2012 Recommended childhood and adolescent immunization schedules--United States, 2012.Pediatrics.  129:385-386. 2012
2012 The authors replyNew England Journal of Medicine.  366:90-91. 2012
2011 Meningococcal conjugate vaccines policy update: booster dose recommendations.Pediatrics.  128:1213-1218. 2011
2011 Oral acyclovir suppression and neurodevelopment after neonatal herpes.New England Journal of Medicine.  365:1284-1292. 2011
2011 Poliovirus.Pediatrics.  128:805-808. 2011
2011 Recommendations for administering hepatitis A vaccine to contacts of international adoptees.Pediatrics.  128:803-804. 2011
2011 The use of systemic and topical fluoroquinolones.Pediatrics.  128:e1034-e1045. 2011
2011 Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.Pediatrics.  128:630-632. 2011
2011 Policy statement—Recommendations for the prevention of perinatal group B streptococcal (GBS) disease.Pediatrics.  128:611-616. 2011
2011 Rabies-prevention policy update: new reduced-dose schedule.Pediatrics.  127:785-787. 2011
2011 Control of varicella disease, version 2.0.Journal of Infectious Diseases.  203:297-299. 2011
2011 Policy statement--recommended childhood and adolescent immunization schedules--United States, 2011.Pediatrics.  127:387-388. 2011
2010 Determination of appropriate dosing of influenza drugs in pediatric patients.Clinical Pharmacology and Therapeutics.  88:704-707. 2010
2010 Policy statement--recommendation for mandatory influenza immunization of all health care personnel.Pediatrics.  126:809-815. 2010
2010 Policy statement--recommendations for prevention and control of influenza in children, 2010-2011.Pediatrics.  126:816-826. 2010
2010 Oseltamivir dosing for influenza infection in premature neonates.Journal of Infectious Diseases.  202:563-566. 2010
2010 Head lice.Pediatrics.  126:392-403. 2010
2010 Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23).Pediatrics.  126:186-190. 2010
2010 Targeted antiviral prophylaxis with oseltamivir in a summer camp setting.Archives of Pediatrics and Adolescent Medicine.  164:323-327. 2010
2010 Safety of oseltamivir compared with the adamantanes in children less than 12 months of age.Pediatric Infectious Disease Journal.  29:195-198. 2010
2010 Pharmacokinetics and safety of extemporaneously compounded valacyclovir oral suspension in pediatric patients from 1 month through 11 years of age.Clinical Infectious Diseases.  50:221-228. 2010
2010 Policy statement--Recommended childhood and adolescent immunization schedules--United States, 2010.Pediatrics.  125:195-196. 2010
2009 From the American Academy of Pediatrics: Policy statements--Modified recommendations for use of palivizumab for prevention of respiratory syncytial virus infections.Pediatrics.  124:1694-1701. 2009
2009 Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system.Journal of Clinical Virology.  46 Suppl 4:S22-S26. 2009
2009 The role of immunoprophylaxis in the reduction of disease attributable to respiratory syncytial virus.Pediatrics.  124:1676-1679. 2009
2009 Policy statement--recommendations for the prevention and treatment of influenza in children, 2009 -2010.Pediatrics.  124:1216-1226. 2009
2009 Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.Antiviral Research.  83:207-213. 2009
2009 Drinking water from private wells and risks to children.Pediatrics.  123:1599-1605. 2009
2009 Drinking water from private wells and risks to children.Pediatrics.  123:e1123-e1137. 2009
2009 Prevention of rotavirus disease: updated guidelines for use of rotavirus vaccine.Pediatrics.  123:1412-1420. 2009
2009 Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies.Journal of Antimicrobial Chemotherapy.  63:862-867. 2009
2009 Correlation of vancomycin dosing to serum concentrations in pediatric patients: a retrospective database review.Journal of Pediatric Pharmacology and Therapeutics.  14:86-93. 2009
2008 Prevention of influenza: recommendations for influenza immunization of children, 2008-2009.Pediatrics.  122:1135-1141. 2008
2008 Exposure to nontraditional pets at home and to animals in public settings: risks to children.Pediatrics.  122:876-886. 2008
2008 When should you initiate acyclovir therapy in a neonate?Journal of Pediatrics.  153:155-156. 2008
2008 Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.Pediatrics.  121:e1016-e1031. 2008
2008 Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease.Journal of Infectious Diseases.  197:836-845. 2008
2008 Recommended immunization schedules for children and adolescents--United States, 2008.Pediatrics.  121:219-220. 2008
2007 Infection prevention and control in pediatric ambulatory settings.Pediatrics.  120:650-665. 2007
2007 Prevention of human papillomavirus infection: provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine.Pediatrics.  120:666-668. 2007
2007 Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.Pediatrics.  120:221-231. 2007
2007 Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation.Clinical Pharmacology and Therapeutics.  81:867-872. 2007
2007 Management of HSV encephalitis in adults and neonates: diagnosis, prognosis and treatment.Herpes -Cambridge-.  14:11-16. 2007
2007 Antiviral therapy and prophylaxis for influenza in children.Pediatrics.  119:852-860. 2007
2007 Prevention of influenza: recommendations for influenza immunization of children, 2006-2007.Pediatrics.  119:846-851. 2007
2007 Varicella-zoster vaccine for the prevention of herpes zoster.New England Journal of Medicine.  356:1338-1343. 2007
2007 Herpes simplex virus infections of the newborn.Seminars in Perinatology.  31:19-25. 2007
2007 Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.Pediatrics.  119:171-182. 2007
2007 Recommended immunization schedules for children and adolescents--United States, 2007.Pediatrics.  119:207-208. 2007
2006 Diagnosis of herpes simplex virus in the era of polymerase chain reaction.Pediatric Infectious Disease Journal.  25:841-842. 2006
2006 The use of systemic fluoroquinolones.Pediatrics.  118:1287-1292. 2006
2006 Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.Pediatrics.  117:965-978. 2006
2005 Herpes simplex virus infections in neonates and early childhood.Seminars in Pediatric Infectious Diseases.  16:271-281. 2005
2005 Diagnosis of herpes simplex virus infections of the CNS.Expert Review of Molecular Diagnostics.  5:537-547. 2005
2005 Antiviral therapies in children: has their time arrived?Pediatric Clinics of North America.  52:837-vii. 2005
2005 Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system.Journal of Infectious Diseases.  191:227-233. 2005
2005 Herpes simplex encephalitis: children and adolescents.Seminars in Pediatric Infectious Diseases.  16:17-23. 2005
2005 Neonatal herpes: what have we learned.Seminars in Pediatric Infectious Diseases.  16:7-16. 2005
2005 Seminars in Pediatric Infectious Diseases: IntroductionSeminars in Pediatric Infectious Diseases.  16:4-5. 2005
2004 Current status of antiviral therapy for juvenile-onset recurrent respiratory papillomatosis.Antiviral Research.  63:141-151. 2004
2004 Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants.Journal of Infectious Diseases.  190:975-978. 2004
2004 Neonatal HSV infections: the global picture.Herpes -Cambridge-.  11:31-32. 2004
2004 Clinical practice. Genital herpes.New England Journal of Medicine.  350:1970-1977. 2004
2004 Clinical practice. Genital herpes.New England Journal of Medicine.  350:1970-1977. 2004
2004 Neonatal herpes simplex infection.Clinical Microbiology Reviews.  17:1-13. 2004
2003 Molecular diagnosis of viral infections of the central nervous system.Clinics in Laboratory Medicine.  23:843-vi. 2003
2003 Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: Results of a randomized, prospective, controlled trialPediatrics.  112:363-367. 2003
2003 Impact of the rapid diagnosis of influenza on physician decision-making and patient management in the pediatric emergency department: results of a randomized, prospective, controlled trial.Pediatrics.  112:363-367. 2003
2003 Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial.Journal of Pediatrics.  143:16-25. 2003
2003 Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitisPediatric Infectious Disease Journal.  22:335-340. 2003
2003 Double blind placebo-controlled trial of pleconaril in infants with enterovirus meningitis.Pediatric Infectious Disease Journal.  22:335-341. 2003
2003 Herpes simplex virus infections of the central nervous system.Seminars in Pediatric Infectious Diseases.  14:83-89. 2003
2003 Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patientsPediatric Infectious Disease Journal.  22:239-244. 2003
2003 Evaluation of multiple drug therapy in human immunodeficiency virus-infected pediatric patients.Pediatric Infectious Disease Journal.  22:239-244. 2003
2002 Herpes simplex virus infections in the neonatal periodInfections in Medicine.  19:462-474. 2002
2002 Pharmacotherapy of recurrent respiratory papillomatosis.Expert Opinion on Pharmacotherapy.  3:1091-1099. 2002
2002 Meningitis in the Neonate.Current Treatment Options in Neurology.  4:239-248. 2002
2002 Antiretroviral pharmacokinetics in the paediatric population: a review.Clinical Pharmacokinetics.  41:1115-1133. 2002
2002 Antiviral therapy for cytomegalovirus infections in pediatric patients.Seminars in Pediatric Infectious Diseases.  13:22-30. 2002
2001 Natural history of neonatal herpes simplex virus infections in the acyclovir eraPediatrics.  108:223-229. 2001
2001 Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infectionsPediatrics.  108:230-238. 2001
2001 Natural history of neonatal herpes simplex virus infections in the acyclovir era.Pediatrics.  108:223-229. 2001
2001 Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.Pediatrics.  108:230-238. 2001
2001 Advances in the treatment of neonatal herpes simplex infections.Reviews in Medical Virology.  11:157-163. 2001
2001 Acyclovir derivatives and other new antiviral agentsSeminars in Pediatric Infectious Diseases.  12:224-234. 2001
2000 Juvenile onset recurrent respiratory papillomatosis: possibilities for successful antiviral therapy.Antiviral Research.  45:83-93. 2000
1999 Viral encephalitis.Pediatrics in Review.  20:192-198. 1999
1999 Neuroinvasion of human herpesviruses 6 and 7Herpes -Cambridge-.  6:60-63. 1999
1998 PCR: A new diagnostic tool that re-defines spectrum of HSV diseaseHerpes -Cambridge-.  5:42-45. 1998
1998 Human herpesvirus-6: neurologic implications of a newly-described viral pathogen.Journal of NeuroVirology.  4:474-485. 1998
1998 Herpes simplex viruses.Clinical Infectious Diseases.  26:541-553. 1998
1998 Human herpesviruses 6 and 7: identification of newly recognized viral pathogens and their association with human disease.Pediatric Infectious Disease Journal.  17:59-67. 1998
1998 Prevention and treatment of congenitally and perinatally acquired herpesvirus infectionsInternational Antiviral News.  6:78-82. 1998
1997 Rubella immunization.Pediatric Annals.  26:366-370. 1997
1997 Treatment of viral infections during pregnancy and the neonatal period.Clinics in Perinatology.  24:267-283. 1997
1997 Prophylaxis and treatment of herpesvirus infections in childrenSeminars in Pediatric Infectious Diseases.  8:196-204. 1997
1996 Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group.Journal of Infectious Diseases.  174:1162-1167. 1996
1996 Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a phase I/II trial.Pediatric Infectious Disease Journal.  15:247-254. 1996
1996 Antiviral resistance: mechanisms, clinical significance, and future implications.Journal of Antimicrobial Chemotherapy.  37:403-421. 1996
1995 Modulation of expression of genes involved in the inflammatory response by lipopolysaccharide and temperature in cultured human astroglial cells.Immunological communications.  24:775-785. 1995
1995 Protein synthesis-dependent induction of interleukin-1 beta by lipopolysaccharide is inhibited by dexamethasone via mRNA destabilization in human astroglial cells.Journal of Clinical Immunology.  15:199-204. 1995
1995 Antiviral resistance in clinical practice.Antiviral Research.  26:423-438. 1995
1995 Antiviral resistance--an emerging problem.Antiviral Research.  26:365-368. 1995
1995 Assays for antiviral drug resistance.Antiviral Research.  26:403-413. 1995
1995 Models of antiviral resistance.Antiviral Research.  26:415-422. 1995
1995 Molecular mechanisms of antiviral resistance.Antiviral Research.  26:369-401. 1995
1995 Research initiatives in studies of antiviral resistance and consensus points and recommendations.Antiviral Research.  26:439-452. 1995

Chapter

Year Title Altmetric
2017 Neurologic sequelae of congenital and perinatal infections.  501-522. 2017
2017 Antiviral Agents.  1551-1567.e6. 2017
2017 Herpes Simplex Virus.  1056-1065.e3. 2017
2017 Introduction to Herpesviridae.  1055-1055.e1. 2017
2017 Neonatal herpes simplex virus infection.  395-410. 2017
2016 Antiviral therapy.  210-225. 2016
2014 Vaccines for viral diseases with significant central nervous system manifestations 2014
2012 Neonatal herpes simplex virus and congenital cytomegalovirus infections.  203-217. 2012
2012 Antiviral Agents.  1502-1518.e10. 2012
2010 Herpes simplex viruses 1 and 2.  1275-1280. 2010
2007 Antiviral therapy of HSV-1 and-2.  1153-1174. 2007
2007 HSV-1 and 2: Pathogenesis and disease.  589-601. 2007
2007 Immunotherapy of HSV infections-Antibody delivery.  1332-1338. 2007
2005 Neonatal herpes simplex virus infection.  395-410. 2005

Principal Investigator On

  • (SCOUT CAP) A Phase IV Double-Blind, Placebo-Controlled, Randomized Trial to Evaluate Short Course vs. Standard Course Outpatient Therapy of Community Acquired Pneumonia in Children Vaccine and Treatment Evaluation Units  awarded by VANDERBILT UNIVERSITY MEDICAL CENTER 2014 - 2023
  • A Phase II, Single-Stage, Single Arm Investigation of Oral Valganciclovir Therapy in Infants with Asymptomatic Congenital Cytomegalovirus Infection  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2021
  • Burden of Neonatal Herpes Simplex Virus Infections: Disease Incidence, Adequacy of Diagnostic Assessment, Disease Outcome, and Societal Costs  awarded by National Institute of Allergy and Infectious Diseases/NIH/DHHS 2016 - 2021
  • Private Grant  awarded by ANTIVIRUS THERAPEUTICS, INC. 2014 - 2019
  • Cross-sectional Cohort Study to Determine the Prevalence of Soil Transmitted Helminth (STH) Infections in School Age Children in a Rural Poor Community in Southern Alabama  awarded by CDC - Centers for Disease Control and Prevention/DHHS 2018 - 2019
  • Monitoring Juvenile Onset Recurrent Respiratory Papillomatosis  awarded by EASTERN VIRGINIA MEDICAL SCHOOL 2017 - 2018
  • Retrospective Assessment of Juvenile Onset Recurrent Respiratory Papillomatosis  awarded by EASTERN VIRGINIA MEDICAL SCHOOL 2017 - 2018
  • Private Grant  awarded by ALIOS BIOPHARMA 2015 - 2018
  • Monitoring Juvenile Onset Recurrent Respiratory Papillomatosis  awarded by EASTERN VIRGINIA MEDICAL SCHOOL 2014 - 2016
  • Efficacy of Antiviral Suppression Therapy after Neonatal HSV Infection of CNS R34 Planning  awarded by Duke University 2015 - 2016
  • Private Grant  awarded by GlaxoSmithKline 2009 - 2015
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2008 - 2014
  • Private Grant  awarded by Gilead Sciences 2013 - 2014
  • Private Grant  awarded by CELLEX, INC. 2010 - 2013
  • Private Grant  awarded by CUBIST PHARMACEUTICALS 2009 - 2012
  • Teaching Activities

  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2019) 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018 - 2019
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2018) 2018
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Spring Term 2017) 2017
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-420 - PEDIATRIC INFECTIOUS DISEASE (Fall Term 2016) 2016
  • 52-401R - RESEARCH IN PEDIATRICS (Fall Term 2007) 2007 - 2008
  • Full Name

  • David Kimberlin